97 related articles for article (PubMed ID: 6966082)
1. Platelet release reaction in vivo in patients with ischaemic heart disease after isometric exercise and its prevention with dipyridamole.
Sano T; Motomiya T; Yamazaki H
Thromb Haemost; 1980 Feb; 42(5):1589-97. PubMed ID: 6966082
[TBL] [Abstract][Full Text] [Related]
2. Platelet Release Reaction in vivo in Patients with Ischaemic Heart Disease after Isometric Exercise and its Prevention with Dipyridamole.
Sano T; Motomiya T; Yamazaki H
Thromb Haemost; 1979 Jul; 42(1):1589-1597. PubMed ID: 30781913
[TBL] [Abstract][Full Text] [Related]
3. Platelet activation in patients with chronic pulmonary heart disease. Effect of dipyridamole treatment.
Zhang X; Ling P
Chin Med J (Engl); 1995 Feb; 108(2):95-7. PubMed ID: 7774397
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of platelet sensitivity to ADP-aggregation by isometric exercise in arteriosclerosis patients and its prevention.
Sano T; Motomiya T; Yamazaki H; Shimamoto T
Thromb Haemost; 1977 Apr; 37(2):329-38. PubMed ID: 195363
[TBL] [Abstract][Full Text] [Related]
5. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease.
Kitai T; Nishikawa M; Tanigawa T; Okinaka T; Wada H; Shiku H; Ikeda Y; Ito M; Isaka N; Nakano T
Am Heart J; 2001 Aug; 142(2):E1. PubMed ID: 11479480
[TBL] [Abstract][Full Text] [Related]
6. Plasma thromboglobulin and platelet aggregation index in transient ischaemic attack: effect of aspirin and dipyridamole therapy.
Aushri Z; Berginer V; Nathan I; Dvilansky A
Int J Clin Pharmacol Res; 1983; 3(5):339-42. PubMed ID: 6206005
[TBL] [Abstract][Full Text] [Related]
7. [Thrombocyte function in physical exertion and induced myocardial ischemia in patients with ischemic heart disease].
Shalaev SV; Panchenko EP; Karasev AV; Pisareva NA; Ovtrakht NV
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1987; 10(2):28-33. PubMed ID: 3426815
[TBL] [Abstract][Full Text] [Related]
8. The aptamer ARC1779 is a potent and specific inhibitor of von Willebrand Factor mediated ex vivo platelet function in acute myocardial infarction.
Spiel AO; Mayr FB; Ladani N; Wagner PG; Schaub RG; Gilbert JC; Jilma B
Platelets; 2009 Aug; 20(5):334-40. PubMed ID: 19637097
[TBL] [Abstract][Full Text] [Related]
9. Platelet proteins (beta-TG and PF4) in atherosclerosis and related diseases.
Mühlhauser I; Schernthaner G; Silberbauer K; Sinzinger H; Kaliman J
Artery; 1980; 8(1):73-9. PubMed ID: 6158934
[TBL] [Abstract][Full Text] [Related]
10. [Platelet activation and endothelial factors in standard exercise test before and after menopause].
Krzysiek J; Milewicz T; Dybkowski R; Janczak-Saif A; Dembińska-Kieć A; Anna AZ; Guevara I; Sztefko K; Radowicki S; Dubiel JS; Klimek R
Przegl Lek; 2001; 58(5):419-25. PubMed ID: 11603175
[TBL] [Abstract][Full Text] [Related]
11. Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic stroke.
Zhao L; Gray L; Leonardi-Bee J; Weaver CS; Heptinstall S; Bath PM
Platelets; 2006 Mar; 17(2):100-4. PubMed ID: 16421011
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the antiplatelet effects of low to medium dose aspirin in the early and late phases after ischaemic stroke and TIA.
McCabe DJ; Harrison P; Mackie IJ; Sidhu PS; Lawrie AS; Purdy G; Machin SJ; Brown MM
Platelets; 2005 Aug; 16(5):269-80. PubMed ID: 16011977
[TBL] [Abstract][Full Text] [Related]
13. A preliminary study on the effects of exercising to maximum walking distance on platelet and endothelial function in patients with intermittent claudication.
Collins P; Ford I; Ball D; Macaulay E; Greaves M; Brittenden J
Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):266-73. PubMed ID: 16360327
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of G-CSF effects on hemostasis in allogeneic blood stem cell donors.
LeBlanc R; Roy J; Demers C; Vu L; Cantin G
Bone Marrow Transplant; 1999 May; 23(10):991-6. PubMed ID: 10373063
[TBL] [Abstract][Full Text] [Related]
15. Plasma indices of endothelial and platelet activation in Rheumatoid Disease: relationship to cardiovascular co-morbidity.
Bhatia GS; Sosin MD; Patel JV; Grindulis KA; Khattak FH; Davis RC; Lip GY
Int J Cardiol; 2009 May; 134(1):97-103. PubMed ID: 18501982
[TBL] [Abstract][Full Text] [Related]
16. Platelet counts and aggregation measures in the incidence of ischaemic heart disease (IHD).
Meade TW; Cooper JA; Miller GJ
Thromb Haemost; 1997 Aug; 78(2):926-9. PubMed ID: 9268196
[TBL] [Abstract][Full Text] [Related]
17. Epinephrine and shear stress synergistically induce platelet aggregation via a mechanism that partially bypasses VWF-GP IB interactions.
Wagner CT; Kroll MH; Chow TW; Hellums JD; Schafer AI
Biorheology; 1996; 33(3):209-29. PubMed ID: 8935180
[TBL] [Abstract][Full Text] [Related]
18. Effects of ticlopidine on von Willebrand factor-mediated shear-induced platelet activation and aggregation.
Goto S; Tamura N; Sakakibara M; Ikeda Y; Handa S
Platelets; 2001 Nov; 12(7):406-14. PubMed ID: 11674857
[TBL] [Abstract][Full Text] [Related]
19. Platelet von Willebrand factor determination does not improve the diagnosis of patients with suspected Type 1 von Willebrand disease.
Shihong I; Morris D; Konkle BA
Haemophilia; 2009 Jan; 15(1):131-4. PubMed ID: 18976254
[TBL] [Abstract][Full Text] [Related]
20. Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study.
Rumley A; Lowe GD; Sweetnam PM; Yarnell JW; Ford RP
Br J Haematol; 1999 Apr; 105(1):110-6. PubMed ID: 10233372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
